Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anqi Lin

Showing results (71-80 of 200) with videos related to

Pageof 20
Sort By:
Molecular Cancer|March 22, 2024
CTLs heterogeneity and plasticity: implications for cancer immunotherapyShengkun Peng, Anqi Lin, Aimin Jiang, et al.
Heliyon|September 19, 2024
Development and validation of a novel immune‒metabolic-Based classifier for hepatocellular carcinomaWenda Zhang, Xinyi Zhou, Lili Lin, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 7, 2022
The role of DNA damage repair (DDR) system in response to immune checkpoint inhibitor (ICI) therapyCongqi Shi, Kaiyu Qin, Anqi Lin, et al.
Cancer Cell International|April 30, 2022
Genomic and immunological profiles of small-cell lung cancer between East Asians and CaucasianAnqi Lin, Ningning Zhou, Weiliang Zhu, et al.
Briefings in Bioinformatics|April 8, 2022
CAMOIP: a web server for comprehensive analysis on multi-omics of immunotherapy in pan-cancerAnqi Lin, Chang Qi, Ting Wei, et al.
Advanced Genetics (Hoboken, N.J.)|December 31, 2025
Translational Aspects of DNA Damage Repair in Optimizing Cancer ChemotherapyAnqi Lin, Jinyue He, Aimin Jiang, et al.
Current Gene Therapy|July 30, 2025
DrugSurvPlot: A Novel Web-Based Platform Harnessing Drug Sensitivity Scores as Molecular Biomarkers for Pan-Cancer Survival PrognosisYing Shi, Qirui Shen, Aimin Jiang, et al.
Frontiers in Pharmacology|September 9, 2020
Prognosis of Lung Adenocarcinoma Patients With NTRK3 Mutations to Immune Checkpoint InhibitorsYuchun Niu, Anqi Lin, Peng Luo, et al.
Molecular Horticulture|December 2, 2025
Strawberry cryptochrome FvCRY1 and FvCRY2 transcriptionally regulate anthocyanin biosynthesis and sugar metabolismLianxi Zhang, Anqi Lin, Xiaoyi Bi, et al.
NPJ Digital Medicine|January 19, 2025
Computational frameworks transform antagonism to synergy in optimizing combination therapiesJinghong Chen, Anqi Lin, Aimin Jiang, et al.
Pageof 20

Showing results (71-80 of 200) with videos related to

Sort By:
Pageof 20
Molecular Cancer|March 22, 2024
CTLs heterogeneity and plasticity: implications for cancer immunotherapyShengkun Peng, Anqi Lin, Aimin Jiang, et al.
Heliyon|September 19, 2024
Development and validation of a novel immune‒metabolic-Based classifier for hepatocellular carcinomaWenda Zhang, Xinyi Zhou, Lili Lin, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 7, 2022
The role of DNA damage repair (DDR) system in response to immune checkpoint inhibitor (ICI) therapyCongqi Shi, Kaiyu Qin, Anqi Lin, et al.
Cancer Cell International|April 30, 2022
Genomic and immunological profiles of small-cell lung cancer between East Asians and CaucasianAnqi Lin, Ningning Zhou, Weiliang Zhu, et al.
Briefings in Bioinformatics|April 8, 2022
CAMOIP: a web server for comprehensive analysis on multi-omics of immunotherapy in pan-cancerAnqi Lin, Chang Qi, Ting Wei, et al.
Advanced Genetics (Hoboken, N.J.)|December 31, 2025
Translational Aspects of DNA Damage Repair in Optimizing Cancer ChemotherapyAnqi Lin, Jinyue He, Aimin Jiang, et al.
Current Gene Therapy|July 30, 2025
DrugSurvPlot: A Novel Web-Based Platform Harnessing Drug Sensitivity Scores as Molecular Biomarkers for Pan-Cancer Survival PrognosisYing Shi, Qirui Shen, Aimin Jiang, et al.
Frontiers in Pharmacology|September 9, 2020
Prognosis of Lung Adenocarcinoma Patients With NTRK3 Mutations to Immune Checkpoint InhibitorsYuchun Niu, Anqi Lin, Peng Luo, et al.
Molecular Horticulture|December 2, 2025
Strawberry cryptochrome FvCRY1 and FvCRY2 transcriptionally regulate anthocyanin biosynthesis and sugar metabolismLianxi Zhang, Anqi Lin, Xiaoyi Bi, et al.
NPJ Digital Medicine|January 19, 2025
Computational frameworks transform antagonism to synergy in optimizing combination therapiesJinghong Chen, Anqi Lin, Aimin Jiang, et al.
Pageof 20